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Objective: To determine patient preference for laparoscopic tubal occlusion or hysteroscopic 
tubal occlusion, two common sterilization interventions, and the acceptability of a postprocedure 
confirmation test for a hysteroscopic approach.
Participants and methods: A total of 100 patients were offered two procedures. A description 
of each procedure was developed and read to each patient by a research nurse on site. Patients were 
then asked to respond to a questionnaire concerning options. Final informed consent, procedure 
review, and procedural date determination were provided by a physician upon completion of 
the questionnaire. Patients were not allowed to change their questionnaire responses after 
completion. No interviewer or physician input was allowed during the questionnaire. The 
study was completed in English or Spanish, as per patient request, by a bilingual/fluent speaker. 
Physicians completing informed consent were unaware of the questionnaire responses. Patients 
were not financially incentivized.
Results: Of 100 participants, 93 (93%) preferred hysteroscopic sterilization to laparoscopy. The 
reasons were as follows: fear of general anesthesia (24/93 [26%]), fear of incision (25/93 [27%]), 
cost (32/93 [34%]), and time (12/93 [13%]) to return to routine activity. All 93 viewed 
“office-based location” as the main advantage over laparoscopy; 88/93 (94.6%) considered a 
confirmation test to be a benefit of the procedure. After informed consent was obtained, one 
additional patient switched from a laparoscopic decision to hysteroscopy (total = 94/100); 89/94 
(95%) hysteroscopic decisions underwent hysteroscopic sterilization; 4/6 (67%) laparoscopic 
decisions proceeded to that surgery. The remainder (N = 7) cancelled due to lack of financial 
resources.
Conclusion: A nonincisional, office-based approach to sterilization has high patient acceptability. 
Patients viewed a confirmatory test for tubal occlusion as a benefit after sterilization.
Keywords: sterilization, hysteroscopy, confirmation testing, laparoscopy, patient preference
Introduction
Sterilization is the most common contraceptive method utilized by couples in the 
USA, with 36% of fertile women using contraception employing this method.1 About 
700,000 female sterilizations are performed annually, half of which are performed 
within 48 hours postpartum2 and the remainder performed as interval procedures that 
do not occur immediately following pregnancy.3 Traditional nonhysteroscopic female 
sterilization techniques carry an overall complication rate of 0.9%–1.6%.4 Access to 
the abdomen is one challenge of laparoscopy, as surgical instruments must be inserted 
through small incisions. Access is therefore associated with injuries to the gastrointes-
tinal tract and major blood vessels and at least 50% of these major complications occur 
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prior to commencement of the intended surgery.5,6 The ability 
to offer female sterilization via a hysteroscopic approach not 
only offers a safer sterilization option but may also increase 
access to care due to in-office performance.7
Numerous authors have published studies on patient satis-
faction and acceptability after hysteroscopic sterilization.8–11 
However, a search of Medline, PubMed, and Medscape 
databases did not retrieve any published articles on patient 
preference (choice) for one method of sterilization over 
another when presented with clear, descriptive briefings 
on laparoscopic and hysteroscopic sterilization techniques. 
This search was not limited to the English language, and 
the keywords “sterilization,” “laparoscopy,” “hysteroscopy,” 
and “Essure®” were employed. Although published reports 
were located on female patients’ attitudes toward the concept 
of sterilization,12,13 no reports queried patients’ preference 
for one sterilization procedure over another. Although some 
may assume that a nonincisional mode of therapy would be 
preferred over traditional laparoscopy, no published data 
exist to support this conclusion. We therefore sought to 
investigate whether a more minimally invasive method of 
tubal sterilization would appeal more to patients requesting 
permanent birth control.
Participants and methods
This research was conducted from January 2008 to March 
2009. Patients referred to the Women’s Specialty Center 
(WSC) Dallas, Texas, for permanent sterilization were 
invited to participate in the study, with a goal of recruit-
ing 100 patients. The Ethical Review Board of the WSC 
granted approval for the investigation. Patients who agreed 
to participate in the study were first asked for a medical 
history and had their vital signs checked by a triage nurse. 
Following this, they were assigned to a research nurse before 
physician contact. Once the patient’s desire for sterilization 
was confirmed, the research nurse proceeded to read scripted 
descriptions of laparoscopic tubal ligation and hysteroscopic 
sterilization (Essure® Hysteroscopic Sterilization System, 
Conceptus Inc, Mountain View, CA; see Table 1) in either 
English or Spanish, according to patient preference. After 
reading each description, the patient was allowed to re-
read the script before answering the study questionnaire 
regarding the sterilization option of choice (Figure 1). 
After questionnaire completion, patients were then directed 
to the attending physician for a formal interview, to have 
their history taken and a physical examination. Informed 
consent for sterilization was also taken at this time. Each 
attending physician was blinded as to whether the patient 
was part of the study as well as to the patient’s choice of 
sterilization method.
Patients declining to participate in the study were directed 
to the attending physician after medical triage for routine 
history and physical examination, interview, and informed 
consent for sterilization.
Each attending physician at WSC routinely offers two 
options for permanent birth control: laparoscopic tubal 
occlusion with titanium clips or office-based hysteroscopic 
sterilization with nitinol/PET micro-inserts. Routine surgical 
informed consent is offered by all WSC physicians accord-
ing to set office protocols. Informed consent includes type 
of procedure descriptions and outlines the risks and ben-
efits, procedure, location where each respective procedure is 
performed – operating room versus consultants’s office setting, 
and postoperative recovery times for all indicated procedures.
The primary outcome measured was the type of steril-
ization favored, based on set scripted descriptions, as well 
as attitudes toward a posthysteroscopic sterilization confir-
mation test. The secondary outcome was percent-decision 
concordance with the study questionnaire prephysician 
consult and choice of sterilization after physician interview 
and consent. Additionally, the percentage of patients who 
actually proceeded to sterilization was determined per 
group. Finally, compliance with posthysteroscopic steriliza-
tion confirmation testing at 12 weeks postprocedure was 
determined.
Results
Patients were referred from a variety of sources: 60% of 
referrals were from family practice groups, 15% from 
women’s health nurse practitioner practices, 20% from 
community family planning clinics, and 5% of patients 
self-referred. Patient demographics are shown in Table 2. 
All patients meeting the inclusion criteria who were offered 
participation accepted. Our goal of 100 subjects was reached 
in March 2009 after beginning in January 2008. Thirty-two 
percent of patients requested to have their sessions in   Spanish. 
After both surgical options were read, 93/100 (93%) patients 
preferred hysteroscopic sterilization over laparoscopy, as 
indicated by the questionnaire results. The reasons declared 
were as follows: fear of general anesthesia (24/93 [26%]), 
fear of incision (25/93 [27%]), cost (32/93 [35%]), and time 
to return to routine activity (12/93 [12.9%]). All 93 viewed 
“office-based location” as the main advantage of hystero-
scopic sterilization over laparoscopy.
Of the 93 patients who chose hysteroscopic sterilization, 
88/93 (94.6%) considered a confirmation test to be a benefit 
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Table 1 Sterilization options offered by our physicians
Option A: Laparoscopy Option B: Hysteroscopy
Description 
5 mm lens (instrument) is placed through the belly button. Gas is placed  
into the abdomen to see the uterus and tubes. Both tubes are clamped  
and blocked from the outside. Gas and instruments are removed.  
You will be taken to recovery room for 1–2 hours before release to home
Description 
5 mm lens (instrument) is placed through your uterine cervix  
(through vagina). Water is placed into the uterus to see the tubal  
openings. The tubes are blocked from the inside. You will have  
5–10 minutes in room for recovery before release to home
Potential risks 
Failure rate: 13/1000 for “all laparoscopic sterilizations” at year 5a,b 
infection 
Bleeding 
intestine/blood vessel injury 
General anesthesia risks
Potential risks 
Failure rate: 2.6/1000 for Essure® hysteroscopic sterilization  
at year 5a,b 
infection 
Local/iV anesthesia risks
Location of procedure: Hospital/Day surgery 
Anesthesia: General 
incisions (cuts): Two, 5 mm each 
After procedure confirmation test 
(verifies whether tubes are blocked): No 
Confirmation test done: No 
Financial: Plan co-pay deductiblec 
Time to heal: 3–5 days 
Birth control effect ready: Same day
Location of procedure: Office 
Anesthesia: Local/iV 
incisions (cuts): none 
After procedure confirmation test 
(verifies whether tubes are blocked): Yes 
Confirmation test done: 3 months later 
Financial: Plan co-pay for office visitc 
Time to heal: 1–2 days 
Birth control effect ready: 3 monthsd
Notes:  aFailure  rates  cited/referenced  from  Brill  Ai  (moderator),  Anderson  TL,  Levie  MD.  Hysteroscopic  Sterilization.  ACOG  Update  (web  based).  2011;36(11)25; 
bPeterson HB, Xia Z, Wilcox LS, Tylor LR, Trussell J. Pregnancy after tubal sterilization with bipolar electrocoagulation. U.S. Collaborative Review of Sterilization 
Working Group. Obstet Gynecol. 1999;94:163–16720; cfinancial responsibility based upon individual insurance plan and coverage; dbirth control may be relied upon once the 
confirmation test shows tubes are blocked.
1. Based upon the given sterilization descriptions, which do you prefer (circle choice)? 
Option A: Laparoscopy  Option B: Hysteroscopy 
2.  What is the most important reason for your decision (TOP 4)? Place #1 by the MOST important, 
#2 for the next most important, etc. The higher the number, the LESS important. 
____Cost 
____Location of procedure 
____Type of anesthesia 
____Fear of anesthesia 
____Return to normal daily function 
____Fear of incision 
Other reason(s):______________________________________________ 
3. Is the confirmation test to check whether the tubes are blocked a benefit? 
____Yes ____No 
4. About you 
(All responses to be used ONLY for research purposes. Your provider will not have the responses 
during your consultation.) 
Age:  ________ 
Ethnic background/Race: African American White Hispanic 
Number of children living:  _________ 
Highest grade level completed:   _________ 
Are you currently working:  _________ 
Past surgeries:   _________ 
Do you smoke cigarettes?  _________ 
What is your average annual income (circle choice)?  
 <$15,000.00   $16,000.00–25,000.00   $26–35,000.00   >$35,000.00 Prefer not to state 
Figure 1 Chapa patient questionnaire.
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of the procedure. After physician consultation was performed 
and informed consent was obtained, an additional patient 
switched from a laparoscopic decision to hysteroscopy (thus, 
94/100); 89/94 (95%) hysteroscopic decisions proceeded to 
and completed sterilization; 4/6 (67%) laparoscopic deci-
sions proceeded to surgery. The remainder (n = 7, five in 
the hysteroscopic group and two in the laparoscopic group) 
cancelled due to lack of financial resources (co-pay funds; 
ie, those unable to provide their required financial portion 
for procedure performance).
Of the 89 hysteroscopic sterilizations performed, 87/89 
(97.7%) had successful bilateral first attempt micro-insert inser-
tions. The remaining two had initial unilateral micro-insert place-
ment due to tubal spasm. Both underwent successful second 
attempts at 1 and 2 weeks after the first attempt, respectively.
Discussion
Hysteroscopic sterilization has been commercially available 
since 2002. Physicians recognize the advantages of hystero-
scopic sterilization as being that it is nonincisional, avoids 
abdominal entry (which may be especially important for 
women with adhesions or comorbidities), can be performed 
as an office procedure, and allows for avoidance of general 
anesthesia.14 Overall, studies have demonstrated high patient 
satisfaction with Essure postprocedure. In a 6-year review of 
Essure, 96%–99% of patients reported satisfaction and comfort 
as “good” to “excellent” during follow-up visits.8 However, no 
peer-reviewed, published work has examined patients’ atti-
tudes or preferences for one modality or the other, in terms of 
offering both options in a standardized, objective format.
Our results indicate that when presented with a clear, 
objective, and factual description of surgical intervention 
options, patients – like physicians – prefer a minimally inva-
sive alternative to traditional surgery. Our analysis has several 
strengths. First, as previously stated, as far as the authors are 
aware, this is the first attempt to determine patients’ prefer-
ences for and attitudes toward sterilization techniques. Addi-
tionally, by including patient perspectives on a postoperative 
confirmation test, we were able to validate the assumption that 
such a test provides “mental reassurance” concerning reliance. 
We sought to eliminate interviewer bias by standardizing the 
initial descriptions of each   procedure. Additionally, to avoid 
variance in message delivery, the research assistants reading 
each script were timed to allow for reproducible sessions. 
Neither of the two research assistants was involved with data 
tabulation or processing. Interestingly, none of the patients 
who chose hysteroscopic sterilization on the questionnaire 
altered their decision after physician consultation.
Another strength of this study it that it followed the cohort 
to the performance of final sterilization. This aids in validat-
ing the notion that surgical decisions actually translated into 
surgical performance. Interestingly, our first-attempt bilateral 
micro-insert placement rate (98%) is in agreement with the 
US Food and Drug Administration’s published rate for the 
Essure system (97%).15
Limitations and future directions
This study did not include patient compliance to confirmation 
test completion. However, this will be the subject of our next 
article, a subanalysis of this cohort (n = 89). Additionally, 
our cohort reflects the sociodemographic characteristics of 
an inner-city population. The application of these findings 
to other sociodemographic groups may be assumed but 
cannot be commented on at this time. In a 2011 report on 
sterilization trends, it was found that men with higher educa-
tion and income had a greater prevalence of vasectomy than 
those less educated, while less-educated women with a lower 
income had the highest prevalence of tubal sterilization.16–18 
However, this report by Anderson et al did not evaluate 
hysteroscopic sterilization as an alternative to female laparo-
scopic sterilization. Clearly, the option of hysteroscopic ster-
ilization and its acceptability across income and educational 
backgrounds must be further described in light of the mini-
mally invasive nature of the procedure. Additionally, we based 
our case study on the Essure Hysteroscopic System only. 
Table 2 Patient demographics (n = 100)
Age Range 34–48, mean 44
Ethnicity 
  African–American 
  Caucasian 
  Hispanic
 
34% 
29% 
37%
Living children 
  #3 
  3–5 
  $5
 
64% 
32% 
4%
Employed Yes 93%
Past surgeries Yes 16%
Cigarette use Yes 7%
income level (USD$) 
  ,15,000.00 
  16,000.00–35,000.00 
  .35,000.00 
  not stated
 
3% 
24% 
68% 
5%
Highest grade level completed 
  #10th 
  #12th 
  College ,2 years 
  College .2 years 
  not stated
 
2% 
63% 
14% 
12% 
9%
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We cannot comment on patient attitudes toward the Adiana® 
Radiofrequency Hysteroscopic System (Hologic Inc, Bed-
ford, MA), as it has not been adopted by the WSC.
In drafting our written script for each respective ster-
ilization procedure, we sought to eliminate observer bias 
by providing factual, realistic, and concrete narrative 
descriptions of both options.19 The failure rate stated for 
laparoscopic tubal ligation (13/1000 at year 5) was chosen 
for the ease of reporting and represents a congregate figure 
of all laparoscopic tubal methods, based on published data.20 
We acknowledge a limitation of our stated laparoscopic 
failure rate (Table 1), since individual laparoscopic ster-
ilization techniques have unique and varied failure rates.20 
For example, according to a US Collaborative Review of 
sterilization study, postprocedural pregnancy rates were 
highest following laparoscopic Hulka-Clemens clip steril-
ization (36.5 pregnancies per 1000 procedures) and lowest 
following unipolar coagulation and postpartum partial 
salpingectomy (7.5 pregnancies per 1000 procedures.19,20 
Additionally, long-term failure rates were found to be closely 
tied to the patient’s age at the time of procedure, with higher 
failure rates for younger patients.20 These points were not 
included in our written script, based on the suspicion that 
their inclusion may confuse those receiving the message. 
It was our intention to provide a reproducible and easy-to-
follow text for each procedure’s narrative. A final limitation 
of this report lies in the use of a nonvalidated questionnaire/
survey of patient preferences.
Physicians are aware of the decreased surgical morbid-
ity that minimally invasive technologies afford. According 
to Kulier et al, laparoscopic sterilization, as compared with 
mini laparotomy, was associated with decreased operative 
morbidity.21 However, risks secondary to abdominal entry 
persist. According to the US Food and Drug Administration, 
the incidence of all-reported laparoscopic trocar injuries 
between 1997 and 2002 was 3%.22 Penetration injury to 
major vessels and/or visera is the most life threatening of 
these injuries. Data are less complete for evaluating the risks 
of the hysteroscopic procedure for micro-insert placement, 
but the use of local anesthesia (with or without sedation) 
and the ability to avoid entering the peritoneal cavity are 
substantial safety advantages. Care must be taken to avoid 
potential complications, including hypervolemia and uterine 
perforation. In the Essure Phase II study and the pivotal 
trial, the latter complication occurred in 2.9% and 1.1% of 
procedures, respectively.23 Based on our analysis, presented 
here, it seems that patients are also aware of the procedural 
morbidity differences between sterilization options.
Conclusion
In closing, as a study, our analysis serves as a tool that 
strongly validates the statistical increase in hysteroscopic 
sterilization since 200224 and validates the assumption that, 
when provided with a choice, patients – like physicians – 
recognize the advantages and benefits of minimally invasive 
technologies.
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